Cargando…

GBA1 in Parkinson’s disease: variant detection and pathogenicity scoring matters

BACKGROUND: GBA1 variants are the strongest genetic risk factor for Parkinson’s disease (PD). However, the pathogenicity of GBA1 variants concerning PD is still not fully understood. Additionally, the frequency of GBA1 variants varies widely across populations. OBJECTIVES: To evaluate Oxford Nanopor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gabbert, Carolin, Schaake, Susen, Lüth, Theresa, Much, Christoph, Klein, Christine, Aasly, Jan O., Farrer, Matthew J., Trinh, Joanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262508/ https://www.ncbi.nlm.nih.gov/pubmed/37312046 http://dx.doi.org/10.1186/s12864-023-09417-y

Ejemplares similares

Benchmarking Low-Frequency Variant Calling With Long-Read Data on Mitochondrial DNA
por: Lüth, Theresa, et al.
Publicado: (2022)

The combined effect of lifestyle factors and polygenic scores on age at onset in Parkinson’s disease
por: Gabbert, Carolin, et al.
Publicado: (2023)

Lifestyle factors and clinical severity of Parkinson’s disease
por: Gabbert, Carolin, et al.
Publicado: (2023)

Nanopore Single-Molecule Sequencing for Mitochondrial DNA Methylation Analysis: Investigating Parkin-Associated Parkinsonism as a Proof of Concept
por: Lüth, Theresa, et al.
Publicado: (2021)

Coffee, smoking and aspirin are associated with age at onset in idiopathic Parkinson’s disease
por: Gabbert, Carolin, et al.
Publicado: (2022)

GBA Variants and Parkinson Disease: Mechanisms and Treatments
por: Smith, Laura, et al.
Publicado: (2022)

GBA1 Variants and Parkinson’s Disease: Paving the Way for Targeted Therapy
por: Huh, Young Eun, et al.
Publicado: (2023)

Characterization of a pathogenic variant in GBA for Parkinson’s disease with mild cognitive impairment patients
por: Jiang, Zhiqiang, et al.
Publicado: (2020)

Improving analysis of the vaginal microbiota of women undergoing assisted reproduction using nanopore sequencing
por: Lüth, Theresa, et al.
Publicado: (2022)

Experience in Genetic Counseling for GBA1 Variants in Parkinson's Disease
por: den Heijer, Jonas M., et al.
Publicado: (2020)

The Consequences of GBA Deficiency in the Autophagy–Lysosome System in Parkinson’s Disease Associated with GBA
por: Pradas, Eddie, et al.
Publicado: (2023)

Brain Regional Differences in Hexanucleotide Repeat Length in X-Linked Dystonia-Parkinsonism Using Nanopore Sequencing
por: Reyes, Charles Jourdan, et al.
Publicado: (2021)

GBA Variants Influence Motor and Non-Motor Features of Parkinson’s Disease
por: Jesús, Silvia, et al.
Publicado: (2016)

Role of Lysosomal Gene Variants in Modulating GBA ‐Associated Parkinson's Disease Risk
por: Straniero, Letizia, et al.
Publicado: (2022)

Elucidating Hexanucleotide Repeat Number and Methylation within the X-Linked Dystonia-Parkinsonism (XDP)-Related SVA Retrotransposon in TAF1 with Nanopore Sequencing
por: Lüth, Theresa, et al.
Publicado: (2022)

Dual-Task Performance in GBA Parkinson's Disease
por: Srulijes, Karin, et al.
Publicado: (2017)

Mitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1/PRKN-linked Parkinson’s disease
por: Trinh, Joanne, et al.
Publicado: (2022)

Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson's Disease Onset
por: Schierding, William, et al.
Publicado: (2020)

Mild dopa-responsive dystonia in heterozygous tyrosine hydroxylase mutation carrier: Evidence of symptomatic enzyme deficiency?
por: Bally, Julien F., et al.
Publicado: (2020)

No evidence for substrate accumulation in Parkinson brains with GBA mutations
por: Gegg, Matthew E., et al.
Publicado: (2015)

Unraveling Autonomic Dysfunction in GBA‐Related Parkinson's Disease
por: Devigili, Grazia, et al.
Publicado: (2023)

Impact of GBA1 variants on long-term clinical progression and mortality in incident Parkinson’s disease
por: Stoker, Thomas B, et al.
Publicado: (2020)

Putative second hit rare genetic variants in families with seemingly GBA-associated Parkinson’s disease
por: Aslam, Muhammad, et al.
Publicado: (2021)

Mutational spectrum and clinical features of GBA1 variants in a Chinese cohort with Parkinson’s disease
por: Zhou, Yangjie, et al.
Publicado: (2023)

Is Gauchian genotyping of GBA1 variants reliable?
por: Tayebi, Nahid, et al.
Publicado: (2023)

α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism
por: Yun, Seung Pil, et al.
Publicado: (2018)

Comparative Transcriptome Analysis in Monocyte-Derived Macrophages of Asymptomatic GBA Mutation Carriers and Patients with GBA-Associated Parkinson’s Disease
por: Usenko, Tatiana, et al.
Publicado: (2021)

Features of GBA-associated Parkinson’s disease at presentation in the UK Tracking Parkinson’s study
por: Malek, Naveed, et al.
Publicado: (2018)

Gene Therapy for Parkinson’s Disease Associated with GBA1 Mutations
por: Abeliovich, Asa, et al.
Publicado: (2021)

Integrated Genetic Analysis of Racial Differences of Common GBA Variants in Parkinson's Disease: A Meta-Analysis
por: Zhang, Yuan, et al.
Publicado: (2018)

Novel Variants in LRRK2 and GBA Identified in Latino Parkinson Disease Cohort Enriched for Caribbean Origin
por: Nuytemans, Karen, et al.
Publicado: (2020)

GBA1 variants in Brazilian Gaucher disease patients
por: Basgalupp, Suelen Porto, et al.
Publicado: (2023)

Genetic association study of synphilin-1 in idiopathic Parkinson's disease
por: Myhre, Ronny, et al.
Publicado: (2008)

The Association between E326K of GBA and the Risk of Parkinson's Disease
por: Huang, Yongpan, et al.
Publicado: (2018)

A Meta-Analysis of GBA-Related Clinical Symptoms in Parkinson's Disease
por: Zhang, Yuan, et al.
Publicado: (2018)

Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's Disease
por: Surface, Matthew, et al.
Publicado: (2021)

GBA1 and The Immune System: A Potential Role in Parkinson’s Disease?
por: Al-Azzawi, Zaid A.M., et al.
Publicado: (2022)

Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson’s disease and their targeted therapeutic approaches: a comprehensive review
por: Behl, Tapan, et al.
Publicado: (2021)

GBA variants influence cognitive status in amyotrophic lateral sclerosis
por: Canosa, Antonio, et al.
Publicado: (2022)

Precision medicine in Parkinson’s disease patients with LRRK2 and GBA risk variants – Let’s get even more personal
por: von Linstow, Christian U., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hg5bmfkst0f0rfvg7jctjmhq3l